BridgeMD
New treatment option for Alcohol Use Disorder
Official title Bright Light Therapy During Residential Alcohol Withdrawal
ClinicalTrials.gov ID: NCT06878287
What this study is testing
- What it's testing
- This is a randomized controlled trial assessing the effectiveness of light therapy versus placebo in patients undergoing alcohol withdrawal.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients must be aged from 18 to 65 years old and have a diagnosis of Alcohol Use Disorder
- Patients must be intreated for alcohol withdrawal, for at least two weeks
- Patients must report heavy drinking episodes in the past month
- Patients must be able to understand medical information and consent to the treatment
- Patients must be considering a goal of abstinence from alcohol
You likely can't join if
- Ophthalmic pathology (cataract, macular degeneration, glaucoma, retinitis pigmentosa) and diseases affecting the retina (retinopathy, diabetes...
- people who have already received light therapy in the last 6 months
- Lactating of pregnant women
- Psychiatric comorbidity requiring an intreatment, or risk of manic episode (people with depressive or anxious symptoms compatible with an...
- Substance Use Disorder other than alcohol and/or tobacco
- Severe cognitive impairment (MOCA \< 10)
See the full eligibility criteria
- Patients must be aged from 18 to 65 years old and have a diagnosis of Alcohol Use Disorder
- Patients must be intreated for alcohol withdrawal, for at least two weeks
- Patients must report heavy drinking episodes in the past month
- Patients must be able to understand medical information and consent to the treatment
- Patients must be considering a goal of abstinence from alcohol
- Ophthalmic pathology (cataract, macular degeneration, glaucoma, retinitis pigmentosa) and diseases affecting the retina (retinopathy, diabetes, herpes, etc.)
- people who have already received light therapy in the last 6 months
- Lactating of pregnant women
- Psychiatric comorbidity requiring an intreatment, or risk of manic episode (people with depressive or anxious symptoms compatible with an out-treatment can be included)
- Substance Use Disorder other than alcohol and/or tobacco
- Severe cognitive impairment (MOCA \< 10)
- Patients being under legal protection measure
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.